PolyPid

About:

PolyPid offers a technology platform that enables a controlled and prolonged release of any active pharmaceutical ingredients (API).

Website: http://www.polypid.com

Top Investors: Dafna Capital Management, Kreos Capital, Financiere Saint James, Apple Core Holdings, Aurum Ventures

Description:

PolyPid is a development stage company that has developed a platform technology for the healthcare industry that enables a controlled and prolonged release of any active pharmaceutical ingredients (API). PolyPid’s technology combines polymers and lipids, enabling small-and-large API entrapment in degradation and hydration protected environments, regardless of their chemical or physical characteristics. PolyPid allows the release of the API from the reservoir at pre-determined rates of up to several months, with a constant release rate (zero-order kinetics). The flexibility of this innovative technology enables local administration of compounds across numerous therapeutic classes for several applications.